Sylvia H Hsu

30PUBLICATIONS
75CO-AUTHORS
Gene and molecular therapyCross-sectional analysisMedical infection agents (incl. prions)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 01, 2026
Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).

|Aug 31, 2026
Adapting a Cancer Cost and Health Insurance Tool for Implementation: Rapid Qualitative Analysis.

|Aug 11, 2026
Association between diabetic control and progression of monoclonal gammopathy of undetermined significance to multiple myeloma.

|Jul 15, 2026
Kidney Transplant Function in Recipients from Deceased Donors with COVID-19.

|May 04, 2026
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma.

|Mar 11, 2026
Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population.

Mei Wang, Byron Sigel, Lawrence Liu

Pageof 5

Frequent Collaborators

10 joint publications

Graham Colditz

7 joint publications

Krista L Lentine

7 joint publications

Martin W Schoen

7 joint publications

Shi-Yi Wang